Leadership Change

As AI floods creative industries, Proudly Human appoints a musician to lead its North American charge for a 'certified human' label. Is this the future of art?

Activist investor PVG Asset Management is launching a full-scale proxy war to oust Anavex's board, citing a crisis of confidence and stalled progress.

CSM (Ret.) John Sampa’s move to the AFBA board is more than a new title; it's a strategic move to embed deep-seated military and first responder insight.

With a new COO, a string of acquisitions, and Morgan Stanley's backing, Security 101 is executing a masterclass in scaling from a regional player to a national powerhouse.

With private equity backing and a new CEO, GDS Associates is poised for aggressive growth. But can it scale without losing its 40-year-old soul?

As high rates and uncertainty plague the housing sector, Evergreen Home Loans makes a bold move, appointing a top strategist to overhaul its construction lending.

Lahontan Gold's appointment of a capital markets veteran as CFO is a clear signal of its intent to restart the Santa Fe Mine and transition into a producer.

With a new CEO, a major investment from PSG, and a founder shifting roles, data firm REBA is poised for its next act. Can it redefine the multifamily market?

As Big Joe Forklifts celebrates 75 years, its new HR VP isn't just a personnel hire. It's a strategic move to build the human capital needed to lead the shift to electric and autonomous systems.

Dr. Timothy Donahue's new leadership at Weill Cornell while on Trethera's board highlights a key trend: integrating top clinical minds to accelerate drug development.

With new board members from Pfizer and Grifols, the DARPA-inspired health nonprofit signals its intent to bridge the gap from lab research to real-world impact.

Construction legend Jay Badame, the man behind One WTC and One Vanderbilt, joins BRAVO Group. Is this the strategic move that vaults a rising firm into the industry's elite?

With tech veteran Dr. Oxana Pickeral as CEO and backing from major PE firms, Ennov is poised to scale its life sciences compliance platform globally.

Karimah Es Sabar, a titan who has raised over $1.5B in bioscience, joins Linearis Ventures. This move signals a major bet on a new model for health-tech investing.

The FiRa Consortium's appointment of UWB commercialization expert Sunil Jogi as President signals a strategic shift from standardization to mass-market adoption.

Skience just appointed Starla Hendricks as CRO. It’s a move signaling a shift from building tech to conquering the market with a leader who speaks fluent ‘ops’.

Remix Therapeutics' hire of Nicole Sweeny is more than a new exec; it's a strategic bet on its RNA platform and a sign of the industry's maturation.

Natilus has a radical aircraft design and a $24 billion order book. But can one new leader steer this vision from blueprint to reality in a skeptical industry?

Eltek taps CFO Ron Freund as its next CEO, signaling a strategic shift toward financial discipline amid operational hurdles and a booming AI-driven PCB market.

Cure Alzheimer's Fund is recruiting top drug developers, including the mind behind Kisunla™, to steer its research—all while refusing industry money.